PhaseLite™ is
clinically proven
Many clinical studies confirm that taking a highly concentrated and standardised glycoprotein complex reduces carbohydrate digestion. Some of the studies are shown below.


1. PhaseLite™ reduces the absorption of starch carbohydrates

A randomised double-blind, crossover human pilot study of PhaseLite™ on human glucose absorption after starch consumption on 11 subjects

PhaseLite™ showed the ability to significantly inhibit starch absorption”

Data on file

Previous | Next

 
Copyright © 2015 by InQpharm Group. All rights reserved. Last updated: Oct 2015 | ID: MP/TM/EN/15/001
Phaselite and InQpharm are trademarks of the InQpharm group of companies.